Skip to main content

Table 3 Results of treatment site-specific lower control limits

From: Investigation of a real-time EPID-based patient dose monitoring safety system using site-specific control limits

Treatment type

Treatment site

Number of plans or patients

Number of fields

Average cumulative χ pass-rate (%) (μ)

Lower control limit (%) (μ-3σ)

IMRT

Prostate

82

1055

89.1

75.6

IMRT

Head and Neck

37

486

84.0

71.3

IMRT

Rectum

18

259

80.9

71.1